发明名称 DRUG MIXTURE WITH ENHANCED DISSOLUTION RATE
摘要 A pharmaceutical composition comprises one or more discrete orally deliverable dosage forms, each comprising a poorly soluble coxib component in an amount effective when administered once daily for treatment or prevention of a COX-2 mediated disorder, an aspirin component in a cardioprotective effective amount when administered once daily, and at least one pharmaceutically acceptable excipient the dosage forms having no substantial barrier to intimate commingling of the coxib and aspirin components. A method of simultaneously treating or preventing a COX-2 mediated disorder and providing cardioprotection comprises orally administering such a pharmaceutical composition to a subject in need thereof.
申请公布号 WO03057196(A1) 申请公布日期 2003.07.17
申请号 WO2003US00367 申请日期 2003.01.07
申请人 PHARMACIA CORP;EWING GARY D;HAWLEY MICHAEL;COFFEY MARTIN J;PRICE JEFFREY E;MACMILLAN STEPHEN P 发明人 EWING GARY D;HAWLEY MICHAEL;COFFEY MARTIN J;PRICE JEFFREY E;MACMILLAN STEPHEN P
分类号 A61K45/00;A61K9/00;A61K9/16;A61K9/20;A61K9/22;A61K9/48;A61K31/365;A61K31/381;A61K31/415;A61K31/42;A61K31/444;A61K31/60;A61K31/616;A61K31/621;A61K45/06;A61P1/02;A61P1/04;A61P1/12;A61P3/10;A61P5/14;A61P7/02;A61P7/06;A61P9/00;A61P9/10;A61P9/14;A61P11/00;A61P11/06;A61P13/12;A61P15/00;A61P17/00;A61P17/02;A61P17/06;A61P19/02;A61P19/04;A61P19/06;A61P19/08;A61P21/00;A61P21/04;A61P25/00;A61P25/04;A61P25/06;A61P27/02;A61P29/00;A61P29/02;A61P31/10;A61P31/18;A61P31/22;A61P35/00;A61P37/02;A61P43/00;(IPC1-7):A61K9/20 主分类号 A61K45/00
代理机构 代理人
主权项
地址